← Leaderboards
Matthew Kyle Hadden
University Of Connecticut Storrs
$3,132,064
Attributed
$4,396,749
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $893.4K · FY2015–23$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,396,749 · 2
By mechanism
R01$4,396,749 · 2
Top collaborators
- Dmitry M. Korzhnev5 shared
Most similar at University Of Connecticut Storrs
Same institution · by research overlap
- James F. Rusling$10,459,986
- Xiao-Bo Zhong$6,614,286
- Kenneth G Campellone$3,714,890
- Tingting Zhao$175,211
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorPathway InteractionsScaffoldSmall MoleculePropertyRelapseResistanceExhibitsResistance DevelopmentMediatingPharmaceutical ChemistryPharmaceutical PreparationsAnalogRegimenMutationFutureDrug KineticsEnsureIn VivoIn VitroLeadMalignant NeoplasmsPublic HealthMouse Model
Grant awards (10)
Inhibition of Translesion Synthesis as a Novel Strategy for Cancer Chemotherapy$495,333
R01 · FY2023 · CA · contact PI
Inhibition of Translesion Synthesis as a Novel Strategy for Cancer Chemotherapy$495,329
R01 · FY2022 · CA · contact PI
Inhibition of Translesion Synthesis as a Novel Strategy for Cancer Chemotherapy$507,870
R01 · FY2021 · CA · contact PI
Inhibition of Translesion Synthesis as a Novel Strategy for Cancer Chemotherapy$507,872
R01 · FY2020 · CA · contact PI
Inhibition of Translesion Synthesis as a Novel Strategy for Cancer Chemotherapy$522,966
R01 · FY2019 · CA · contact PI
Itraconazole Analogues to Treat Medulloblastoma$370,476
R01 · FY2019 · CA · contact PI
Itraconazole Analogues to Treat Medulloblastoma$382,211
R01 · FY2018 · CA · contact PI
Itraconazole Analogues to Treat Medulloblastoma$382,472
R01 · FY2017 · CA · contact PI
Itraconazole Analogues to Treat Medulloblastoma$367,973
R01 · FY2016 · CA · contact PI
Itraconazole Analogues to Treat Medulloblastoma$364,247
R01 · FY2015 · CA · contact PI